Ted Monohon - Net Worth and Insider Trading
Ted Monohon Net Worth
The estimated net worth of Ted Monohon is at least $21,678 dollars as of 2024-06-09. Ted Monohon is the Chief Accounting Officer & VP of Quince Therapeutics Inc and owns about 27,440 shares of Quince Therapeutics Inc (QNCX) stock worth over $21,678. Details can be seen in Ted Monohon's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Ted Monohon has not made any transactions after 2023-03-06 and currently still holds the listed stock(s).
Transaction Summary of Ted Monohon
Ted Monohon Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Ted Monohon owns 1 companies in total, including Quince Therapeutics Inc (QNCX) .
Click here to see the complete history of Ted Monohon’s form 4 insider trades.
Insider Ownership Summary of Ted Monohon
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| QNCX | Quince Therapeutics Inc | 2023-03-06 | Chief Accounting Officer |
Ted Monohon Latest Holdings Summary
Ted Monohon currently owns a total of 1 stock. Ted Monohon owns 27,440 shares of Quince Therapeutics Inc (QNCX) as of March 6, 2023, with a value of $21,678.
Latest Holdings of Ted Monohon
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| QNCX | Quince Therapeutics Inc | 2023-03-06 | 27,440 | 0.79 | 21,678 |
Holding Weightings of Ted Monohon
Ted Monohon Form 4 Trading Tracker
According to the SEC Form 4 filings, Ted Monohon has made a total of 1 transactions in Quince Therapeutics Inc (QNCX) over the past 5 years, including 0 buys and 1 sells. The most-recent trade in Quince Therapeutics Inc is the sale of 1,871 shares on March 6, 2023, which brought Ted Monohon around $1,834.
Insider Trading History of Ted Monohon
- 1
Ted Monohon Trading Performance
Ted Monohon Ownership Network
Ted Monohon Owned Company Details
What does Quince Therapeutics Inc do?
Who are the key executives at Quince Therapeutics Inc?
Ted Monohon is the Chief Accounting Officer of Quince Therapeutics Inc. Other key executives at Quince Therapeutics Inc include Chief Scientific Officer Guenter Janhofer , President Charles S. Ryan , and director & Chief Executive Officer Dirk Thye .
Quince Therapeutics Inc (QNCX) Insider Trades Summary
Over the past 18 months, Ted Monohon made 1 insider transaction in Quince Therapeutics Inc (QNCX) with a net sale of 1,871. Other recent insider transactions involving Quince Therapeutics Inc (QNCX) include a net purchase of 500,436 shares made by David Lamond , a net purchase of 168,000 shares made by Dirk Thye , and a net purchase of 71,762 shares made by Brendan Hannah .
In summary, during the past 3 months, insiders sold 0 shares of Quince Therapeutics Inc (QNCX) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 1,871 shares of Quince Therapeutics Inc (QNCX) were sold and 748,198 shares were bought by its insiders, resulting in a net purchase of 746,327 shares.
Quince Therapeutics Inc (QNCX)'s detailed insider trading history can be found in Insider Trading Tracker table.
Quince Therapeutics Inc Insider Transactions
Ted Monohon Mailing Address
Above is the net worth, insider trading, and ownership report for Ted Monohon. You might contact Ted Monohon via mailing address: C/o Fantex, Inc., 330 Townsend St., Suite 234, San Francisco Ca 94107.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
